Human and Mouse Cell Isolation and Phenotyping
Human and Mouse Cell Isolation and Phenotyping
批准号:
8391963
负责人:
Andrew S Weyrich
金额:
$53.22万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2012
资助国家:
美国
项目状态:
已结题
起止时间:
2012-05-01 至 2017-04-30
关键词:
Biological AssayBloodBlood ClotBlood PlateletsBlood coagulationBreedingCell SeparationCellsCenter for Translational Science ActivitiesDiabetes MellitusEnsureEquipmentGenerationsGlucoseHousingHumanIn VitroIncubatorsInstructionLipidsMaintenanceMedicineMegakaryocytesMetabolicMetabolic syndromeMolecular MedicineMusNon-Insulin-Dependent Diabetes MellitusObesityPatientsPhenotypePlatelet Function TestsPopulationResearch PersonnelResearch Project GrantsResourcesRiskServicesSterilityThrombosisTissuesUniversitiesUtahWorkcomparativediabetes managementin vivoinsightmouse modelprograms
中文摘要
项目总结(见说明):
人类和小鼠细胞分离和表型核心(核心C)将为犹他州大学血栓形成分子医学转化研究中心(U2 M2-TRCT)计划的所有四个研究项目提供服务。核心C位于中心位置,所有U2 M2-TRCT研究人员都可以立即使用。核心将分离人和小鼠巨核细胞和血小板用于U2 M2-TRCT
研究人员,进行标准的体外和体内血小板功能测定,协助项目1和2中提出的遗传操作小鼠的产生、繁殖和维持,并管理肥胖和糖尿病小鼠模型。核心C由一组在所有基本核心活动方面具有优势和专业知识的调查人员领导。为了标准化研究中的巨核细胞和血小板群体,核心C将为所有U2 M2-TRCT研究者分离和培养巨核细胞和血小板。在这方面核心C将直接与核心B沟通,以确保从肥胖和糖尿病患者中无缝分离血小板。核心还将直接与项目1和2进行细胞分离,代谢表型分析和相关功能分析。核心配备了细胞分选仪和无菌
用于分离和培养纯化的人和小鼠巨核细胞和血小板的培养箱。此外,该中心还配备了用于体外和体内分析血小板功能和小鼠代谢表型的设备,这些设备将用于项目1和2。核心研究人员还将共同努力,产生,繁殖和维持项目1和2中提出的小鼠群体。U2 M2-TRCT计划将使用
核心C提供的专门知识和资源,以指导和指导项目1-4中提议的研究。
英文摘要
PROJECT SUMMARY (See instructions):
The Human and Mouse Cell Isolation and Phenotyping Core (Core C) will provide services for all four research projects in the University of Utah Molecular Medicine Translational Research Center in Thrombosis (U2M2-TRCT) program. Core C is centrally located and immediately available to all U2M2-TRCT investigators. The core will isolate human and mouse megakaryocytes and platelets for U2M2-TRCT
investigators, perform standard in vitro and in vivo platelet function assays, assist with generation, breeding, and maintenance of genetically manipulated mice proposed in projects 1 and 2, and manage mouse models of obesity and diabetes. Core C is led by a group of investigators with strengths and expertise in all of the essential core activities. In order to standardize populations of megakaryocytes and platelets among studies, Core C will isolate and culture megakaryocytes and platelets for all U2M2-TRCT investigators. In this regard. Core C will communicate directly with Core B to ensure seamless isolation of platelets from patients with obesity and diabetes. The Core will also directly communicate with projects 1 and 2 for cell isolation, metabolic phenotyping, and related functional analyses. The Core is equipped with a cell sorter and sterile
incubators for isolation and culture of purified human and mouse megakaryocytes and platelets. In addition, the core has equipment for in vitro and in vivo analyses of platelet function and metabolic phenotyping of mice that will be used in projects 1 and 2. Core investigators will also work together to generate, breed, and maintain colonies of mice that are proposed in projects 1 and 2. The U2M2-TRCT program will use the
expertise and resources provided by Core C to guide and direct studies proposed in projects 1-4.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Translational Control of Megakaryocyte and Platelet Gene Expression in Disease
-
批准号:10616557
-
项目类别:
-
资助金额:$71.22万
-
财政年份:2019
-
负责人:Andrew S Weyrich
-
依托单位:
Translational Control of Megakaryocyte and Platelet Gene Expression in Disease
-
批准号:10569253
-
项目类别:
-
资助金额:$73.09万
-
财政年份:2019
-
负责人:Andrew S Weyrich
-
依托单位:
2014 Hemostasis Gordon Research Conference and Gordon Research Seminar
-
批准号:8784662
-
项目类别:
-
资助金额:$1.25万
-
财政年份:2014
-
负责人:Andrew S Weyrich
-
依托单位:
Patient Enrollment and Data Analysis
-
批准号:8464249
-
项目类别:
-
资助金额:$31.89万
-
财政年份:2013
-
负责人:Andrew S Weyrich
-
依托单位:
Platelet Reprogramming in Human Obesity and Diabetes
-
批准号:8464247
-
项目类别:
-
资助金额:$62.26万
-
财政年份:2013
-
负责人:Andrew S Weyrich
-
依托单位:
Administrative
-
批准号:8391960
-
项目类别:
-
资助金额:$16.55万
-
财政年份:2012
-
负责人:Andrew S Weyrich
-
依托单位:
Reprogrammed Platelets: Effectors of Thrombosis in Metabolic Syndromes
-
批准号:9068226
-
项目类别:
-
资助金额:$252.7万
-
财政年份:2012
-
负责人:Andrew S Weyrich
-
依托单位:
Reprogrammed Platelets: Effectors of Thrombosis in Metabolic Syndromes
-
批准号:8464229
-
项目类别:
-
资助金额:$252.4万
-
财政年份:2012
-
负责人:Andrew S Weyrich
-
依托单位:
Platelet Reprogramming in Human Obesity and Diabetes
-
批准号:8391959
-
项目类别:
-
资助金额:$66.61万
-
财政年份:2012
-
负责人:Andrew S Weyrich
-
依托单位:
Reprogrammed Platelets: Effectors of Thrombosis in Metabolic Syndromes
-
批准号:8656415
-
项目类别:
-
资助金额:$261.08万
-
财政年份:2012
-
负责人:Andrew S Weyrich
-
依托单位:
Reprogrammed Platelets: Effectors of Thrombosis in Metabolic Syndromes
-
批准号:8250544
-
项目类别:
-
资助金额:$266.69万
-
财政年份:2012
-
负责人:Andrew S Weyrich
-
依托单位:
The Molecular Regulation of Platelet Reprogramming by the Metabolic Milieu
-
批准号:8391955
-
项目类别:
-
资助金额:$34.59万
-
财政年份:2012
-
负责人:Andrew S Weyrich
-
依托单位:
Metabolic Regulation of Platelet Reprogramming
-
批准号:8391957
-
项目类别:
-
资助金额:$34.26万
-
财政年份:2012
-
负责人:Andrew S Weyrich
-
依托单位:
Patient Enrollment and Data Analysis
-
批准号:8391962
-
项目类别:
-
资助金额:$33.54万
-
财政年份:2012
-
负责人:Andrew S Weyrich
-
依托单位:
Translational Research Skills Development Core
-
批准号:8392583
-
项目类别:
-
资助金额:$11.76万
-
财政年份:2012
-
负责人:Andrew S Weyrich
-
依托单位:
The Role of the Metabolic Milieu In Regulating Platelet Reprogramming in Humans
-
批准号:8391958
-
项目类别:
-
资助金额:$16.16万
-
财政年份:2012
-
负责人:Andrew S Weyrich
-
依托单位:
PAR-04-122 Extramural Facilities Construction Grant. "F*
-
批准号:7000557
-
项目类别:
-
资助金额:$800.0万
-
财政年份:2010
-
负责人:Andrew S Weyrich
-
依托单位:
Reverse Transcriptase Activity in Megakaryocytes and Platelets
-
批准号:7845031
-
项目类别:
-
资助金额:$18.81万
-
财政年份:2009
-
负责人:Andrew S Weyrich
-
依托单位:
Novel Thrombotic and Inflammatory Activities of Platelets in Sepsis
-
批准号:7851203
-
项目类别:
-
资助金额:$52.82万
-
财政年份:2009
-
负责人:Andrew S Weyrich
-
依托单位:
Reverse Transcriptase Activity in Megakaryocytes and Platelets
-
批准号:7359528
-
项目类别:
-
资助金额:$22.58万
-
财政年份:2009
-
负责人:Andrew S Weyrich
-
依托单位:
海外基金